rss
BMJ Case Reports 2009; doi:10.1136/bcr.11.2008.1239
  • Novel treatment (new drug/intervention; established drug/procedure in new situation)

Cultivated autologous limbal epithelial transplantation for symptomatic bullous keratopathy

  1. Yoshiyuki Satake,
  2. Shigeto Shimmura,
  3. Jun Shimazaki
  1. Tokyo Dental College, Ophthalmology, 5-11-13 Sugano, Ichikawa, Chiba, 272-8513, Japan
  1. Yoshiyuki Satake, satake{at}eyebank.or.jp
  • Published 14 April 2009

Summary

We report the clinical outcome of cultivated autologous limbal epithelial transplantation for symptomatic bullous keratopathy in an 87-year-old female patient presenting with recurrent corneal erosion and intractable ocular pain. The patient refused corneal transplantation, and transplantation of a cultivated autologous limbal epithelial sheet was carried out to free her of the symptoms associated with chronic pseudophakic bullous keratopathy. Both integrity of transplanted epithelium and relief from intolerable ocular pain were achieved and maintained immediately after surgery. No complications were noted in either the transplanted eye or donor eye during the 43-month follow-up period. Our findings support that patients with bullous keratopathy not consenting to procedures to improve visual acuity in whom the primary aim is relief of symptoms may benefit from cultivated autologous limbal epithelial transplantation.

Footnotes

  • Competing interests: none.

  • Patient consent: Patient/guardian consent was obtained for publication.

Register for free content

The full text of all Editor's Choice articles and summaries of every article are free without registration

The full text of Images in ... articles are free to registered users

Only fellows can access the full text of case reports (apart from Editor's Choice) - become a fellow today, or encourage your institution to, so that together we can grow and develop this resource

Don't forget to sign up for content alerts so you keep up to date with all the case reports as they are published, and let us know what you think by commenting on the Editor's blog

Navigate This Article